精神障碍中应答、缓解、康复与复发候选预测因素的总括性综述
该总括性综述检索MEDLINE/Embase至2022年7月19日,纳入117篇系统综述、403项研究、299,888名精神障碍患者,测试796个预测模型,旨在识别诊断特异性/跨诊断/跨结局的多变量候选预测因素(MCP)。仅4.3%系统综述和1.2%单项研究为低偏倚风险;识别出多个应答、缓解和复发的MCP,但无康复的MCP。
要点
- 跨诊断缓解MCP包括较低疾病特异性症状、女性/高教育、生活质量/功能。
- 跨诊断复发MCP包括较高疾病特异性症状、较高抑郁症状、年轻年龄等。
- 男性、年轻、更多临床及共病症状为不良预后因素,社会接触与就业为积极因素。
核心结论
- 识别出多个诊断特异性、跨诊断和跨结局的MCP,可指导未来预测模型的开发、验证或优化。
研究设计与样本
- 总括性综述,检索MEDLINE/Embase至2022年7月19日,纳入117篇系统综述、403项研究、299,888名DSM/ICD定义的精神障碍患者,测试796个预测模型。
主要发现
- 仅4.3%的系统综述和1.2%的单项研究为低偏倚风险。
- 最常针对的结局是缓解(36.9%),最少为康复(2.5%)。
- 研究主要聚焦抑郁(39.4%)、物质使用(17.9%)和精神分裂症谱系(11.9%)障碍。
- 识别出多个应答、缓解和复发的MCP,但无康复的MCP。
- 跨诊断缓解MCP包括较低疾病特异性症状(5种障碍)、女性/高教育(3种障碍)、生活质量/功能(2种障碍)。
关键数值与推荐
- 抑郁的跨结局积极MCP包括较少负性生活事件/抑郁症状(应答、缓解、较少复发)、女性(应答、缓解)、更好功能(应答、较少复发)。
- 精神分裂症的跨结局积极MCP包括较少阳性症状/较高抑郁症状(缓解、较少复发)。
- 物质使用障碍的跨结局积极MCP包括已婚状态/高教育(缓解、较少复发)。
- 不良预后因素包括男性、年轻、更多临床及共病精神/躯体症状/障碍。
- 积极因素包括社会接触与就业、无负性生活事件、高教育、早期获得/干预、较低疾病特异性及共病精神/躯体症状/状况。
临床怎么用
- 识别的MCP可用于未来精神障碍关键结局预测模型的开发、验证或优化。
局限性
- 当前数据局限性包括研究高偏倚风险以及从多变量模型中提取单一预测因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We aimed to identify diagnosis-specific/transdiagnostic/transoutcome multivariable candidate predictors (MCPs) of key outcomes in mental disorders. We conducted an umbrella review (protocol link ), searching MEDLINE/Embase (19/07/2022), including systematic reviews of studies reporting on MCPs of response, remission, recovery, or relapse, in DSM/ICD-defined mental disorders. From published predictors, we filtered MCPs, validating MCP criteria. AMSTAR2/PROBAST measured quality/risk of bias of systematic reviews/individual studies. We included 117 systematic reviews, 403 studies, 299,888 individuals with mental disorders, testing 796 prediction models. Only 4.3%/1.2% of the systematic reviews/individual studies were at low risk of bias. The most frequently targeted outcome was remission (36.9%), the least frequent was recovery (2.5%). Studies mainly focused on depressive (39.4%), substance-use (17.9%), and schizophrenia-spectrum (11.9%) disorders. We identified numerous MCPs within disorders for response, remission and relapse, but none for recovery. Transdiagnostic MCPs of remission included lower disease-specific symptoms (disorders = 5), female sex/higher education (disorders = 3), and quality of life/functioning (disorders = 2). Transdiagnostic MCPs of relapse included higher disease-specific symptoms (disorders = 5), higher depressive symptoms (disorders = 3), and younger age/higher anxiety symptoms/global illness severity/ number of previous episodes/negative life events (disorders = 2). Finally, positive trans-outcome MCPs for depression included less negative life events/depressive symptoms (response, remission, less relapse), female sex (response, remission) and better functioning (response, less relapse); for schizophrenia, less positive symptoms/higher depressive symptoms (remission, less relapse); for substance use disorder, marital status/higher education (remission, less relapse). Male sex, younger age, more clinical symptoms and comorbid mental/physical symptoms/disorders were poor prognostic factors, while positive factors included social contacts and employment, absent negative life events, higher education, early access/intervention, lower disease-specific and comorbid mental and physical symptoms/conditions, across mental disorders. Current data limitations include high risk of bias of studies and extraction of single predictors from multivariable models. Identified MCPs can inform future development, validation or refinement of prediction models of key outcomes in mental disorders.
引用
- Solmi M, Cortese S, Vita G, et al. An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders. Mol Psychiatry. 2023. PMID: 37957292. doi:10.1038/s41380-023-02298-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。